Hosted on MSN3h
Biotech Market Forecast: Top Trends for Biotech in 2025
The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...
Hosted on MSN3h
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
Medical marijuana users can become addicted to pot, study says
People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...
Medscape6h
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
TheHealthSite7h
US FDA Approves First Of Its Kind Ketamine-Based Nasal Spray To Treat Depression: Know All About This Drug
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
ScienceAlert22h
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.